Previous investigations have shown that rat adrenocortical cells are provided with galanin receptors, and galanin stimulates glucocorticoid secretion from dispersed cells. The present study aimed to clarify the possible role of galanin in the physiological regulation of rat adrenal secretory activity. Reverse transcription-polymerase chain reaction detected galanin mRNA expression in the adrenal medulla, but not in the cortex. Sizeable concentrations of galanin-immunoreactivity were measured by radioimmune assay only in the adrenomedullary tissue. Galanin raised norepinephrine, but not epinephrine, release from adrenomedullary tissue. Galanin immunoneutralization (obtained with concentrations of anti-galanin antibody able to block the galanin glucocorticoid secretagogue effect on dispersed adrenocortical cells) decreased basal corticosterone production from adrenal slices containing adrenomedullary tissue, without affecting that from dispersed adrenocortical cells. The ß-adrenoceptor antagonist l-alprenolol partially prevented galanin-stimulated corticosterone secretion from adrenal slices, without per se altering basal secretion. Taken together, our findings allow us to conclude that endogenous galanin, produced in adrenal medulla, is involved in the regulation of adrenocortical glucocorticoid secretion acting via a two-fold paracrine mechanism: i) direct activation of adrenocortical galanin receptors; and ii) stimulation of adrenomedullary release of catecholamines, which in turn activate ß-adrenoceptors located on adrenocortical cells.
Introduction
Galanin is a regulatory peptide, which is widely distributed in the central and peripheral nervous system, where it acts as a neuromodulator (reviewed in ref. 1) . Recent findings showed that galanin enhances glucocorticoid (corticosterone), but not mineralocorticoid (aldosterone) secretion from dispersed rat inner adrenocortical cells, acting via GAL-R1 and GAL-R2 receptors coupled to the adenylate cyclase-dependent signaling cascade (2) .
Evidence indicates that adrenomedullary cells express the galanin gene (3) (4) (5) , and radioimmune assay (RIA)-measurable galanin immunoreactivity (IR) was detected in fresh rat adrenal medulla (6, 7) . These observations could suggest a role for galanin in the regulation of adrenomedullary functions, but in vitro investigations on the effect of this peptide on catecholamine secretion are lacking.
Therefore, it seemed worthwhile to examine in vitro the effects of galanin on catecholamine secretion, and to ascertain whether, as in the case of other regulatory peptides contained in medullary chromaffin cells (reviewed in ref. 8) , the possible interactions of galanin with adrenomedullary cells may concur to the secretagogue action of this peptide on the adrenal cortex.
Materials and methods

Animals and reagents.
Male Sprague-Dawley rats (200-250 g body weight) were provided by Charles-River (Como, Italy). Rats were decapitated, and their adrenals were promptly removed and cleaned of adherent fat. The protocol of the experiment was approved by the local Ethics Committee for Biomedical Studies. Rat galanin and anti-rat galanin antibody were purchased from Phoenix Pharmaceuticals (Belmont, CA). Medium 199 was obtained from Difco (Detroit, MI). Human serum albumin (HSA), l-alprenolol, and all other chemicals and laboratory reagents were provided by SigmaAldrich Corporation (St. Louis, MO).
Reverse transcription (RT)-polymerase chain reaction (PCR).
Total RNA was extracted from the frozen adrenal cortex and medulla, and reverse transcribed to cDNA (9-11).
PCR was performed in a Delfi 100 thermal cycler (MT Research Inc., Waterstone, MA), as previously detailed (12) (13) (14) . As positive control, the expression of the housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was detected, and to rule out the possibility of amplifying genomic DNA, one PCR was carried out without prior RT of the RNA. Detection of the PCR amplification products was performed by size fractionation on 2% agarose-gel electrophoresis. The specificity of the PCR was verified by sequencing analysis (15) . Primer sequence, predicted size of amplicons, and PCR program are indicated in the legend of Fig. 1 .
Galanin-RIA. Fresh preweighed adrenal cortex and medulla samples were extracted, as previously detailed (16) . Galanin concentration was measured, using the rat-galanin RIA kit of Phoenix Pharmaceuticals; sensitivity, 210 pg/ml; crossreactivity, rat galanin, 100% and other peptides, 0%; and intraassay and interassay CVs: 7% and 9%, respectively.
Preparation of adrenal specimens. Adrenals were decapsulated to eliminate zona glomerulosa, and then halved and enucleated to separate adrenal medulla from inner zona fasciculata-reticularis. Dispersed inner adrenocortical cells were obtained by sequential collagenase digestion and mechanical disaggregation (17) . Other adrenals were sliced, and slices containing both cortical and medullary tissues (4-6 mg of tissue) were selected. Adrenomedullary tissue, dispersed cells and adrenal slices were placed (10 5 cells or 4-6 mg tissue/ml) in Medium 199 and Krebs-Ringer bicarbonate buffer with 0.2% glucose and 5 mg/ml HSA, and incubated as described below.
Experimental design. Dispersed inner adrenocortical cells were incubated as follows: i) galanin (10 -8 M) in the presence of increasing concentrations of anti-galanin antibody (1-6 μg/ ml); and ii) anti-galanin antibody (4 or 6 μg/ml). Adrenomedullary tissue was incubated with increasing concentrations of galanin (10 -12 -10 -6 M). Adrenal slices were incubated as follows: i) anti-galanin antibody (4 or 6 μg/ml); and ii) antigalanin antibody (6 μg/ml) and/or l-alprenolol (10 -5 M) in the presence or absence of galanin (10 -6 M). Incubation was carried out for 60 min (steroid hormone production) or 30 min (catecholamine production) in a shaking bath at 37˚C in an atmosphere of 95% air-5% CO 2 . At the end of the experiments, the incubation tubes were centrifuged at 4˚C, and media were collected and stored at -80˚C.
Hormone assay. Corticosterone was extracted from incubation media and purified by high pressure liquid chromatography (HPLC) (18) , and its concentration was measured by RIA, as previously described (19, 20) ; sensitivity, 50 pg/ml; and intraassay and interassay CVs, 7.2 and 8.5%, respectively. Epinephrine (E) and nor-epinephrine (NE) concentrations were measured by HPLC, using a reverse phase column and glassy carbon electrochemical detector (21, 22) ; sensitivity, 3 fmol/ml; and intraassay and interassay CVs, 6.4 and 7.9%, respectively.
Statistics. Data were expressed as means ± SD or SEM of the number of independent experiments indicated in the figure legends. Statistical analysis was carried out by ANOVA, followed by Duncan's multiple range test.
Results
RT-PCR detected the expression of galanin mRNA in the rat adrenal medulla (Fig. 1) , but not adrenal cortex (data not shown). RIA measured sizeable concentrations of galanin-IR in the rat adrenal medulla (82.7±23.2 SD pmol/g; n=10); in the adrenal cortex the concentrations of the peptide were below the limit of sensitivity of our assay. Similar to our previous study (2), galanin (10 -8 M) enhanced ~3-fold the corticosterone secretion from dispersed rat inner adrenocortical cells. Corticosterone response to galanin was inhibited by anti-galanin antibody exposure in a concentration-dependent manner, a complete blockade being obtained with an antibody concentration of 5-6 μg/ml (Fig. 2) .
Galanin, at concentrations ranging from 10 -8 -10 -6 M, raised NE secretion from rat adrenomedullary tissue (from 20 to 30%), while E production was not affected (Fig. 3) . The exposure to the maximal effective concentration of antigalanin antibody did not alter either basal NE secretion from adrenomedullary tissue (data not shown) or basal corticosterone secretion from dispersed inner adrenocortical cells (Fig. 4) . However, it evoked a significant lowering of corticosterone secretion from adrenal slices (-22%) (Fig. 4) . Antigalanin antibody lowered both basal-and galanin (10 -6 M) stimulated corticosterone secretion from adrenal slices, while l-alprenolol (10 -5 M) decreased only galanin-stimulated production (Fig. 5) .
Discussion
Our present findings clearly show that galanin is expressed in the rat adrenal medulla as mRNA and protein. RIA detected galanin concentrations >80 pmol/g, which, as previously calculated (8) , can give rise to local intra-adrenal levels of the peptide of ~10 -7 /10 -6 M. This finding, along with the demonstration of the presence of galanin receptors in adrenocortical and adrenomedullary cells (2) and the fact that in the rat the blood level of galanin does not exceed 10 -10 M (23), strongly suggest that galanin may modulate adrenocortical function in a paracrine manner. Our present study gives support to this contention, and also indicates that the endogenous galanin/galanin receptor system plays a relevant role in the physiological regulation of adrenocortical secretion.
This contention is based on the evidence that the exposure of adrenocortical slices, containing adrenal medulla and hence sizeable levels of endogenous galanin, to anti-galanin antibodies lowers basal secretion of corticosterone. The antibodies are able to block the galanin-stimulated corticosterone secretion from dispersed rat zona fasciculata-reticularis cells, but not their basal corticosterone secretion, which accords well with the lack of endogenous galanin in rat adrenocortical tissue.
Many lines of evidence indicate that several adrenomedullary peptides are able to regulate adrenocortical function through a two-fold paracrine mechanism (reviewed in ref. 8 ). (29, 30) , and ANP (31) .
The following pieces of evidence allow us to include galanin in this group of regulatory peptides: i) galanin enhances NE release from rat medullary cells; ii) the ß-adrenoceptor antagonist l-alprenolol (8) partially prevents galanin-stimulated corticosterone secretion from adrenal slices; and iii) l-alprenolol per se does not alter basal corticosterone production from adrenal slices, thereby ruling out the possibility that the effect of this antagonist was due to a nonspecific toxic effect on the steroidogenic pathways of adrenocortical cells. This last observation makes it unlikely that catecholamine release may be involved in the regulatory effect of endogenous galanin on corticosterone secretion under basal conditions, and this contention agrees with the lack of effect of the exposure to anti-galanin antibodies on the basal catecholamine secretion from adrenomedullary tissue. Hence, it seems reasonable to hypothesize that only paraphysiological or pathological conditions able to elicit massive galanin release within adrenal medulla may allow this peptide to reach local concentrations sufficient to evoke catecholamine secretion.
In conclusion, our study provides evidence suggesting that endogenous galanin may be involved in the paracrine control of glucocorticoid secretion from rat adrenal cortex, and investigations are underway to ascertain which are the possible stimuli able to modulate galanin release from medullary chromaffin cells.
